Respinova Ltd.
Pressure-pulsation home-use device for managing COPD
This article was originally published in Start Up
Executive Summary
Respinova Ltd. has developed a noninvasive home-use device to help patients manage COPD’s debilitating symptoms. The PulseHaler is similar to continuous positive airway pressure devices used for sleep apnea, but it is designed to treat the very small terminal airways that are blocked as a result of COPD.
You may also be interested in...
Bellwether Wuxi Biologics' Plunge Indicative Of China Biotech Challenges
Major Chinese biopharma contract services group WuXi Biologics' share price plummeted after it said external factors would contribute to it missing original revenue targets this year in multiple areas.
Cosmetic And Personal Care Weekly Trademarks Review: 5 December
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
As Biopharma Seeks Broader IRA Orphan Exclusion, Study Urges Boosting Savings By Eliminating It
Research takes deep dive into the implications around exempting certain orphan drugs that may qualify for the Inflation Reduction Act’s Medicare price negotiation program, including the effect of the exemption on Medicare spending and the revenue potential of those drugs.